Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-17-156366
Filing Date
2017-05-03
Accepted
2017-05-03 16:56:19
Documents
8
Effectiveness Date
2017-05-03

Document Format Files

Seq Description Document Type Size
1 F-1MEF d382824df1mef.htm F-1MEF 40688
2 EX-5.1 d382824dex51.htm EX-5.1 14725
3 EX-23.1 d382824dex231.htm EX-23.1 3395
4 GRAPHIC g382824g26u27.jpg GRAPHIC 2304
5 GRAPHIC g382824g40x27.jpg GRAPHIC 17584
6 GRAPHIC g382824g56n90.jpg GRAPHIC 17587
7 GRAPHIC g382824g74m96.jpg GRAPHIC 47222
8 GRAPHIC g382824g93b55.jpg GRAPHIC 47442
  Complete submission text file 0001193125-17-156366.txt   242498
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1MEF | Act: 33 | File No.: 333-217631 | Film No.: 17809978
SIC: 2834 Pharmaceutical Preparations